![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Bevacizumab in Ovarian Cancer: State of the Art and Unanswered Questions
Publisher: Karger
E-ISSN: 1421-9794|62|2|111-120
ISSN: 0009-3157
Source: Chemotherapy, Vol.62, Iss.2, 2016-10, pp. : 111-120
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract